Back to Search
RANDALL DAYNES, MD
MD
Family Medicine Physician
NPI: 1811962939Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
1653701205(UT)
Research & Publications (20)
Role of redox imbalance in the molecular mechanisms responsible for immunosenescence.
PMID 14580308·Antioxid Redox Signal·2003
7-preclinical
TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses.
PMID 19299729·J Immunol·2009
7-preclinical
TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines.
PMID 18178294·Vaccine·2008
7-preclinical
Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.
PMID 18765736·Infect Immun·2008
7-preclinical
Human Salmonella clinical isolates distinct from those of animal origin.
PMID 18245251·Appl Environ Microbiol·2008
7-preclinical
Macrophages from 11beta-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-beta-mediated up-regulation of SHIP1 expression.
PMID 17947710·J Immunol·2007
7-preclinical
In vivo-selected mutations in methyl-directed mismatch repair suppress the virulence attenuation of Salmonella dam mutant strains following intraperitoneal, but not oral, infection of naïve mice.
PMID 17468250·J Bacteriol·2007
7-preclinical
Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway.
PMID 17277160·J Immunol·2007
7-preclinical
Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties.
PMID 17092617·Vaccine·2007
7-preclinical
The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities.
PMID 15634910·J Immunol·2005
7-preclinical
The impact of an extreme sports event on a district general hospital.
PMID 16163995·Scott Med J·2005
4-observational
Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation.
PMID 12816998·J Immunol·2003
7-preclinical
Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis.
PMID 12460901·Cancer Res·2002
7-preclinical
A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology.
PMID 12296295·Proc Nutr Soc·2002
6-review
The induction of systemic and mucosal immunity to protein vaccines delivered through skin sites exposed to UVB.
PMID 11972981·Vaccine·2002
7-preclinical
Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.
PMID 11726654·J Biol Chem·2002
7-preclinical
CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice.
PMID 11738152·Exp Gerontol·2001
7-preclinical
Salmonella DNA adenine methylase mutants confer cross-protective immunity.
PMID 11598044·Infect Immun·2001
7-preclinical
Ganglioside control over IL-4 priming and cytokine production in activated T cells.
PMID 10880242·Cytokine·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 999 MURRAY HOLLADAY RD, SUITE 207
SALT LAKE CITY, UT 84117 - Phone
- (801) 268-2584
Quick Facts
- NPI
- 1811962939
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile